Abstract:Anthocyanins, found in various pigmented plants as secondary metabolites, represent a class of dietary polyphenols known for their bioactive properties, demonstrating health-promoting effects against several chronic diseases. Among these, cyanidin-3-O-glucoside (C3G) is one of the most prevalent types of anthocyanins. Upon consumption, C3G undergoes phases I and II metabolism by oral epithelial cells, absorption in the gastric epithelium, and gut transformation (phase II & microbial metabolism), with limited amounts reaching the bloodstream. Obesity, characterized by excessive body fat accumulation, is a global health concern associated with heightened risks of disability, illness, and mortality. This comprehensive review delves into the biodegradation and absorption dynamics of C3G within the gastrointestinal tract. It meticulously examines the latest research findings, drawn from in vitro and in vivo models, presenting evidence underlining C3G's bioactivity. Notably, C3G has demonstrated significant efficacy in combating obesity, by regulating lipid metabolism, specifically decreasing lipid synthesis, increasing fatty acid oxidation, and reducing lipid accumulation. Additionally, C3G enhances energy homeostasis by boosting energy expenditure, promoting the activity of brown adipose tissue, and stimulating mitochondrial biogenesis. Furthermore, C3G shows potential in managing various prevalent obesity-related conditions. These include cardiovascular diseases (CVD) and hypertension through the suppression of reactive oxygen species (ROS) production, enhancement of endogenous antioxidant enzyme levels, and inhibition of the nuclear factor-kappa B (NF-κB) signaling pathway and by exercising its cardioprotective and vascular effects by decreasing pulmonary artery thickness and systolic pressure which enhances vascular relaxation and angiogenesis. Type 2 diabetes mellitus (T2DM) and insulin resistance (IR) are also managed by reducing gluconeogenesis via AMPK pathway activation, promoting autophagy, protecting pancreatic β-cells from oxidative stress and enhancing glucose-stimulated insulin secretion. Additionally, C3G improves insulin sensitivity by upregulating GLUT-1 and GLUT-4 expression and regulating the PI3K/Akt pathway. C3G exhibits anti-inflammatory properties by inhibiting the NF-κB pathway, reducing pro-inflammatory cytokines, and shifting macrophage polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype. C3G demonstrates antioxidative effects by enhancing the expression of antioxidant enzymes, reducing ROS production, and activating the Nrf2/AMPK signaling pathway. Moreover, these mechanisms also contribute to attenuating inflammatory bowel disease and regulating gut microbiota by decreasing Firmicutes and increasing Bacteroidetes abundance, restoring colon length, and reducing levels of inflammatory cytokines. The therapeutic potential of C3G extends beyond metabolic disorders; it has also been found effective in managing specific cancer types and neurodegenerative disorders. The findings of this research can provide an important reference for future investigations that seek to improve human health through the use of naturally occurring bioactive compounds.

A Review of the Role of an Anthocyanin, Cyanidin-3- O- β-glucoside in Obesity-Related Complications

Recent advances on cyanidin-3-O-glucoside in preventing obesity-related metabolic disorders: A comprehensive review

The Influence of Supplementation of Anthocyanins on Obesity-Associated Comorbidities: A Concise Review

Revisiting Dietary Proanthocyanidins on Blood Glucose Homeostasis from a Multi-Scale Structural Perspective

An Updated Review on Chemical Compositions, Biological Capabilities, and Clinical Benefits of Cranberries

Cyanidin 3-Glucoside Attenuates Obesity-Associated Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed and Db/db Mice Via the Transcription Factor FoxO1.

Dose‐dependent effects of anthocyanin‐rich extracts on obesity‐induced inflammation and gut microbiota modulation

The Benefits of Anthocyanins against Obesity-Induced Inflammation

A dietary anthocyanin cyanidin-3-O-glucoside binds to PPARs to regulate glucose metabolism and insulin sensitivity in mice

Cyanidin-3-O-β-glucoside, a Typical Anthocyanin, Exhibits Antilipolytic Effects in 3T3-L1 Adipocytes During Hyperglycemia: Involvement of FoxO1-mediated Transcription of Adipose Triglyceride Lipase.

Health benefits of cyanidin-3-glucoside as a potent modulator of Nrf2-mediated oxidative stress

Inhibitory Effects of Sweet Cherry Anthocyanins on the Obesity Development in C57bl/6 Mice

Front Cover: Cyanidin‐3‐glucoside Increases Whole Body Energy Metabolism by Upregulating Brown Adipose Tissue Mitochondrial Function

Recent Advances in Understanding the Anti-Obesity Activity of Anthocyanins and Their Biosynthesis in Microorganisms

The update of anthocyanins on obesity and type 2 diabetes: Experimental evidence and clinical perspectives

Cyanidin-3-O-β-glucoside improves obesity and triglyceride metabolism in KK-Ay mice by regulating lipoprotein lipase activity.

Cyanidin-3-glucoside increases whole body energy metabolism by upregulating brown adipose tissue mitochondrial function.

Cyanidin-3-glucoside Attenuates High-Fat and High-Fructose Diet-Induced Obesity by Promoting the Thermogenic Capacity of Brown Adipose Tissue

Anthocyanins As Promising Molecules and Dietary Bioactive Components Against Diabetes – A Review of Recent Advances

Targets and mechanisms of dietary anthocyanins to combat hyperglycemia and hyperuricemia: a comprehensive review

Dietary Effects of Anthocyanins in Human Health: A Comprehensive Review